Medical Care
Global Natural Killer Cell Therapy Market Research Report 2025
- Apr 16, 25
- ID: 188389
- Pages: 72
- Figures: 74
- Views: 45
The global market for Natural Killer Cell Therapy was valued at US$ 393 million in the year 2024 and is projected to reach a revised size of US$ 1758 million by 2031, growing at a CAGR of 24.2% during the forecast period.
Cell therapy, a new therapeutic approach that uses a patient"s own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body"s first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.
Based on application, the market is classified into cancer, gastrointestinal diseases and others. The cancer segment accounted for a major share in 2019 (66.99%).
Major players operating in the market include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics and etc. The Top 6 players accounted for 96.66% of the global revenue market share in 2019.
This report aims to provide a comprehensive presentation of the global market for Natural Killer Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Natural Killer Cell Therapy.
The Natural Killer Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Natural Killer Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Natural Killer Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Glycostem Therapeutics
Fate Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
Nkarta Therapeutics
NantKwest
Segment by Type
NK Cell Therapies
NK Cell Directed Antibodies
Segment by Application
Cancer
Gastrointestinal Diseases
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Natural Killer Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Cell therapy, a new therapeutic approach that uses a patient"s own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body"s first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.
Based on application, the market is classified into cancer, gastrointestinal diseases and others. The cancer segment accounted for a major share in 2019 (66.99%).
Major players operating in the market include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics and etc. The Top 6 players accounted for 96.66% of the global revenue market share in 2019.
This report aims to provide a comprehensive presentation of the global market for Natural Killer Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Natural Killer Cell Therapy.
The Natural Killer Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Natural Killer Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Natural Killer Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Glycostem Therapeutics
Fate Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
Nkarta Therapeutics
NantKwest
Segment by Type
NK Cell Therapies
NK Cell Directed Antibodies
Segment by Application
Cancer
Gastrointestinal Diseases
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Natural Killer Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Natural Killer Cell Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 NK Cell Therapies
1.2.3 NK Cell Directed Antibodies
1.3 Market by Application
1.3.1 Global Natural Killer Cell Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer
1.3.3 Gastrointestinal Diseases
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Natural Killer Cell Therapy Market Perspective (2020-2031)
2.2 Global Natural Killer Cell Therapy Growth Trends by Region
2.2.1 Global Natural Killer Cell Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Natural Killer Cell Therapy Historic Market Size by Region (2020-2025)
2.2.3 Natural Killer Cell Therapy Forecasted Market Size by Region (2026-2031)
2.3 Natural Killer Cell Therapy Market Dynamics
2.3.1 Natural Killer Cell Therapy Industry Trends
2.3.2 Natural Killer Cell Therapy Market Drivers
2.3.3 Natural Killer Cell Therapy Market Challenges
2.3.4 Natural Killer Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Natural Killer Cell Therapy Players by Revenue
3.1.1 Global Top Natural Killer Cell Therapy Players by Revenue (2020-2025)
3.1.2 Global Natural Killer Cell Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Natural Killer Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Natural Killer Cell Therapy Revenue
3.4 Global Natural Killer Cell Therapy Market Concentration Ratio
3.4.1 Global Natural Killer Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Natural Killer Cell Therapy Revenue in 2024
3.5 Global Key Players of Natural Killer Cell Therapy Head office and Area Served
3.6 Global Key Players of Natural Killer Cell Therapy, Product and Application
3.7 Global Key Players of Natural Killer Cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Natural Killer Cell Therapy Breakdown Data by Type
4.1 Global Natural Killer Cell Therapy Historic Market Size by Type (2020-2025)
4.2 Global Natural Killer Cell Therapy Forecasted Market Size by Type (2026-2031)
5 Natural Killer Cell Therapy Breakdown Data by Application
5.1 Global Natural Killer Cell Therapy Historic Market Size by Application (2020-2025)
5.2 Global Natural Killer Cell Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Natural Killer Cell Therapy Market Size (2020-2031)
6.2 North America Natural Killer Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Natural Killer Cell Therapy Market Size by Country (2020-2025)
6.4 North America Natural Killer Cell Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Natural Killer Cell Therapy Market Size (2020-2031)
7.2 Europe Natural Killer Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Natural Killer Cell Therapy Market Size by Country (2020-2025)
7.4 Europe Natural Killer Cell Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Natural Killer Cell Therapy Market Size (2020-2031)
8.2 Asia-Pacific Natural Killer Cell Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Natural Killer Cell Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Natural Killer Cell Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Natural Killer Cell Therapy Market Size (2020-2031)
9.2 Latin America Natural Killer Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Natural Killer Cell Therapy Market Size by Country (2020-2025)
9.4 Latin America Natural Killer Cell Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Natural Killer Cell Therapy Market Size (2020-2031)
10.2 Middle East & Africa Natural Killer Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Natural Killer Cell Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Natural Killer Cell Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Nektar Therapeutics
11.1.1 Nektar Therapeutics Company Details
11.1.2 Nektar Therapeutics Business Overview
11.1.3 Nektar Therapeutics Natural Killer Cell Therapy Introduction
11.1.4 Nektar Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025)
11.1.5 Nektar Therapeutics Recent Development
11.2 Innate Pharma SA
11.2.1 Innate Pharma SA Company Details
11.2.2 Innate Pharma SA Business Overview
11.2.3 Innate Pharma SA Natural Killer Cell Therapy Introduction
11.2.4 Innate Pharma SA Revenue in Natural Killer Cell Therapy Business (2020-2025)
11.2.5 Innate Pharma SA Recent Development
11.3 Affimed
11.3.1 Affimed Company Details
11.3.2 Affimed Business Overview
11.3.3 Affimed Natural Killer Cell Therapy Introduction
11.3.4 Affimed Revenue in Natural Killer Cell Therapy Business (2020-2025)
11.3.5 Affimed Recent Development
11.4 Chipscreen Biosciences
11.4.1 Chipscreen Biosciences Company Details
11.4.2 Chipscreen Biosciences Business Overview
11.4.3 Chipscreen Biosciences Natural Killer Cell Therapy Introduction
11.4.4 Chipscreen Biosciences Revenue in Natural Killer Cell Therapy Business (2020-2025)
11.4.5 Chipscreen Biosciences Recent Development
11.5 Glycostem Therapeutics
11.5.1 Glycostem Therapeutics Company Details
11.5.2 Glycostem Therapeutics Business Overview
11.5.3 Glycostem Therapeutics Natural Killer Cell Therapy Introduction
11.5.4 Glycostem Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025)
11.5.5 Glycostem Therapeutics Recent Development
11.6 Fate Therapeutics
11.6.1 Fate Therapeutics Company Details
11.6.2 Fate Therapeutics Business Overview
11.6.3 Fate Therapeutics Natural Killer Cell Therapy Introduction
11.6.4 Fate Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025)
11.6.5 Fate Therapeutics Recent Development
11.7 Dragonfly Therapeutics
11.7.1 Dragonfly Therapeutics Company Details
11.7.2 Dragonfly Therapeutics Business Overview
11.7.3 Dragonfly Therapeutics Natural Killer Cell Therapy Introduction
11.7.4 Dragonfly Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025)
11.7.5 Dragonfly Therapeutics Recent Development
11.8 Kiadis Pharma
11.8.1 Kiadis Pharma Company Details
11.8.2 Kiadis Pharma Business Overview
11.8.3 Kiadis Pharma Natural Killer Cell Therapy Introduction
11.8.4 Kiadis Pharma Revenue in Natural Killer Cell Therapy Business (2020-2025)
11.8.5 Kiadis Pharma Recent Development
11.9 Nkarta Therapeutics
11.9.1 Nkarta Therapeutics Company Details
11.9.2 Nkarta Therapeutics Business Overview
11.9.3 Nkarta Therapeutics Natural Killer Cell Therapy Introduction
11.9.4 Nkarta Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025)
11.9.5 Nkarta Therapeutics Recent Development
11.10 NantKwest
11.10.1 NantKwest Company Details
11.10.2 NantKwest Business Overview
11.10.3 NantKwest Natural Killer Cell Therapy Introduction
11.10.4 NantKwest Revenue in Natural Killer Cell Therapy Business (2020-2025)
11.10.5 NantKwest Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Natural Killer Cell Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 NK Cell Therapies
1.2.3 NK Cell Directed Antibodies
1.3 Market by Application
1.3.1 Global Natural Killer Cell Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer
1.3.3 Gastrointestinal Diseases
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Natural Killer Cell Therapy Market Perspective (2020-2031)
2.2 Global Natural Killer Cell Therapy Growth Trends by Region
2.2.1 Global Natural Killer Cell Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Natural Killer Cell Therapy Historic Market Size by Region (2020-2025)
2.2.3 Natural Killer Cell Therapy Forecasted Market Size by Region (2026-2031)
2.3 Natural Killer Cell Therapy Market Dynamics
2.3.1 Natural Killer Cell Therapy Industry Trends
2.3.2 Natural Killer Cell Therapy Market Drivers
2.3.3 Natural Killer Cell Therapy Market Challenges
2.3.4 Natural Killer Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Natural Killer Cell Therapy Players by Revenue
3.1.1 Global Top Natural Killer Cell Therapy Players by Revenue (2020-2025)
3.1.2 Global Natural Killer Cell Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Natural Killer Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Natural Killer Cell Therapy Revenue
3.4 Global Natural Killer Cell Therapy Market Concentration Ratio
3.4.1 Global Natural Killer Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Natural Killer Cell Therapy Revenue in 2024
3.5 Global Key Players of Natural Killer Cell Therapy Head office and Area Served
3.6 Global Key Players of Natural Killer Cell Therapy, Product and Application
3.7 Global Key Players of Natural Killer Cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Natural Killer Cell Therapy Breakdown Data by Type
4.1 Global Natural Killer Cell Therapy Historic Market Size by Type (2020-2025)
4.2 Global Natural Killer Cell Therapy Forecasted Market Size by Type (2026-2031)
5 Natural Killer Cell Therapy Breakdown Data by Application
5.1 Global Natural Killer Cell Therapy Historic Market Size by Application (2020-2025)
5.2 Global Natural Killer Cell Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Natural Killer Cell Therapy Market Size (2020-2031)
6.2 North America Natural Killer Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Natural Killer Cell Therapy Market Size by Country (2020-2025)
6.4 North America Natural Killer Cell Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Natural Killer Cell Therapy Market Size (2020-2031)
7.2 Europe Natural Killer Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Natural Killer Cell Therapy Market Size by Country (2020-2025)
7.4 Europe Natural Killer Cell Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Natural Killer Cell Therapy Market Size (2020-2031)
8.2 Asia-Pacific Natural Killer Cell Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Natural Killer Cell Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Natural Killer Cell Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Natural Killer Cell Therapy Market Size (2020-2031)
9.2 Latin America Natural Killer Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Natural Killer Cell Therapy Market Size by Country (2020-2025)
9.4 Latin America Natural Killer Cell Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Natural Killer Cell Therapy Market Size (2020-2031)
10.2 Middle East & Africa Natural Killer Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Natural Killer Cell Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Natural Killer Cell Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Nektar Therapeutics
11.1.1 Nektar Therapeutics Company Details
11.1.2 Nektar Therapeutics Business Overview
11.1.3 Nektar Therapeutics Natural Killer Cell Therapy Introduction
11.1.4 Nektar Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025)
11.1.5 Nektar Therapeutics Recent Development
11.2 Innate Pharma SA
11.2.1 Innate Pharma SA Company Details
11.2.2 Innate Pharma SA Business Overview
11.2.3 Innate Pharma SA Natural Killer Cell Therapy Introduction
11.2.4 Innate Pharma SA Revenue in Natural Killer Cell Therapy Business (2020-2025)
11.2.5 Innate Pharma SA Recent Development
11.3 Affimed
11.3.1 Affimed Company Details
11.3.2 Affimed Business Overview
11.3.3 Affimed Natural Killer Cell Therapy Introduction
11.3.4 Affimed Revenue in Natural Killer Cell Therapy Business (2020-2025)
11.3.5 Affimed Recent Development
11.4 Chipscreen Biosciences
11.4.1 Chipscreen Biosciences Company Details
11.4.2 Chipscreen Biosciences Business Overview
11.4.3 Chipscreen Biosciences Natural Killer Cell Therapy Introduction
11.4.4 Chipscreen Biosciences Revenue in Natural Killer Cell Therapy Business (2020-2025)
11.4.5 Chipscreen Biosciences Recent Development
11.5 Glycostem Therapeutics
11.5.1 Glycostem Therapeutics Company Details
11.5.2 Glycostem Therapeutics Business Overview
11.5.3 Glycostem Therapeutics Natural Killer Cell Therapy Introduction
11.5.4 Glycostem Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025)
11.5.5 Glycostem Therapeutics Recent Development
11.6 Fate Therapeutics
11.6.1 Fate Therapeutics Company Details
11.6.2 Fate Therapeutics Business Overview
11.6.3 Fate Therapeutics Natural Killer Cell Therapy Introduction
11.6.4 Fate Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025)
11.6.5 Fate Therapeutics Recent Development
11.7 Dragonfly Therapeutics
11.7.1 Dragonfly Therapeutics Company Details
11.7.2 Dragonfly Therapeutics Business Overview
11.7.3 Dragonfly Therapeutics Natural Killer Cell Therapy Introduction
11.7.4 Dragonfly Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025)
11.7.5 Dragonfly Therapeutics Recent Development
11.8 Kiadis Pharma
11.8.1 Kiadis Pharma Company Details
11.8.2 Kiadis Pharma Business Overview
11.8.3 Kiadis Pharma Natural Killer Cell Therapy Introduction
11.8.4 Kiadis Pharma Revenue in Natural Killer Cell Therapy Business (2020-2025)
11.8.5 Kiadis Pharma Recent Development
11.9 Nkarta Therapeutics
11.9.1 Nkarta Therapeutics Company Details
11.9.2 Nkarta Therapeutics Business Overview
11.9.3 Nkarta Therapeutics Natural Killer Cell Therapy Introduction
11.9.4 Nkarta Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025)
11.9.5 Nkarta Therapeutics Recent Development
11.10 NantKwest
11.10.1 NantKwest Company Details
11.10.2 NantKwest Business Overview
11.10.3 NantKwest Natural Killer Cell Therapy Introduction
11.10.4 NantKwest Revenue in Natural Killer Cell Therapy Business (2020-2025)
11.10.5 NantKwest Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Natural Killer Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of NK Cell Therapies
Table 3. Key Players of NK Cell Directed Antibodies
Table 4. Global Natural Killer Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Natural Killer Cell Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Natural Killer Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Natural Killer Cell Therapy Market Share by Region (2020-2025)
Table 8. Global Natural Killer Cell Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Natural Killer Cell Therapy Market Share by Region (2026-2031)
Table 10. Natural Killer Cell Therapy Market Trends
Table 11. Natural Killer Cell Therapy Market Drivers
Table 12. Natural Killer Cell Therapy Market Challenges
Table 13. Natural Killer Cell Therapy Market Restraints
Table 14. Global Natural Killer Cell Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Natural Killer Cell Therapy Market Share by Players (2020-2025)
Table 16. Global Top Natural Killer Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cell Therapy as of 2024)
Table 17. Ranking of Global Top Natural Killer Cell Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Natural Killer Cell Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Natural Killer Cell Therapy, Headquarters and Area Served
Table 20. Global Key Players of Natural Killer Cell Therapy, Product and Application
Table 21. Global Key Players of Natural Killer Cell Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Natural Killer Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Natural Killer Cell Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global Natural Killer Cell Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Natural Killer Cell Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global Natural Killer Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Natural Killer Cell Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global Natural Killer Cell Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Natural Killer Cell Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America Natural Killer Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Natural Killer Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Natural Killer Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Natural Killer Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Natural Killer Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Natural Killer Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Natural Killer Cell Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Natural Killer Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Natural Killer Cell Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Natural Killer Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Natural Killer Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Natural Killer Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Natural Killer Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Natural Killer Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Natural Killer Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Nektar Therapeutics Company Details
Table 47. Nektar Therapeutics Business Overview
Table 48. Nektar Therapeutics Natural Killer Cell Therapy Product
Table 49. Nektar Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025) & (US$ Million)
Table 50. Nektar Therapeutics Recent Development
Table 51. Innate Pharma SA Company Details
Table 52. Innate Pharma SA Business Overview
Table 53. Innate Pharma SA Natural Killer Cell Therapy Product
Table 54. Innate Pharma SA Revenue in Natural Killer Cell Therapy Business (2020-2025) & (US$ Million)
Table 55. Innate Pharma SA Recent Development
Table 56. Affimed Company Details
Table 57. Affimed Business Overview
Table 58. Affimed Natural Killer Cell Therapy Product
Table 59. Affimed Revenue in Natural Killer Cell Therapy Business (2020-2025) & (US$ Million)
Table 60. Affimed Recent Development
Table 61. Chipscreen Biosciences Company Details
Table 62. Chipscreen Biosciences Business Overview
Table 63. Chipscreen Biosciences Natural Killer Cell Therapy Product
Table 64. Chipscreen Biosciences Revenue in Natural Killer Cell Therapy Business (2020-2025) & (US$ Million)
Table 65. Chipscreen Biosciences Recent Development
Table 66. Glycostem Therapeutics Company Details
Table 67. Glycostem Therapeutics Business Overview
Table 68. Glycostem Therapeutics Natural Killer Cell Therapy Product
Table 69. Glycostem Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025) & (US$ Million)
Table 70. Glycostem Therapeutics Recent Development
Table 71. Fate Therapeutics Company Details
Table 72. Fate Therapeutics Business Overview
Table 73. Fate Therapeutics Natural Killer Cell Therapy Product
Table 74. Fate Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025) & (US$ Million)
Table 75. Fate Therapeutics Recent Development
Table 76. Dragonfly Therapeutics Company Details
Table 77. Dragonfly Therapeutics Business Overview
Table 78. Dragonfly Therapeutics Natural Killer Cell Therapy Product
Table 79. Dragonfly Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025) & (US$ Million)
Table 80. Dragonfly Therapeutics Recent Development
Table 81. Kiadis Pharma Company Details
Table 82. Kiadis Pharma Business Overview
Table 83. Kiadis Pharma Natural Killer Cell Therapy Product
Table 84. Kiadis Pharma Revenue in Natural Killer Cell Therapy Business (2020-2025) & (US$ Million)
Table 85. Kiadis Pharma Recent Development
Table 86. Nkarta Therapeutics Company Details
Table 87. Nkarta Therapeutics Business Overview
Table 88. Nkarta Therapeutics Natural Killer Cell Therapy Product
Table 89. Nkarta Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025) & (US$ Million)
Table 90. Nkarta Therapeutics Recent Development
Table 91. NantKwest Company Details
Table 92. NantKwest Business Overview
Table 93. NantKwest Natural Killer Cell Therapy Product
Table 94. NantKwest Revenue in Natural Killer Cell Therapy Business (2020-2025) & (US$ Million)
Table 95. NantKwest Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Natural Killer Cell Therapy Picture
Figure 2. Global Natural Killer Cell Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Natural Killer Cell Therapy Market Share by Type: 2024 VS 2031
Figure 4. NK Cell Therapies Features
Figure 5. NK Cell Directed Antibodies Features
Figure 6. Global Natural Killer Cell Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Natural Killer Cell Therapy Market Share by Application: 2024 VS 2031
Figure 8. Cancer Case Studies
Figure 9. Gastrointestinal Diseases Case Studies
Figure 10. Others Case Studies
Figure 11. Natural Killer Cell Therapy Report Years Considered
Figure 12. Global Natural Killer Cell Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Natural Killer Cell Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Natural Killer Cell Therapy Market Share by Region: 2024 VS 2031
Figure 15. Global Natural Killer Cell Therapy Market Share by Players in 2024
Figure 16. Global Top Natural Killer Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cell Therapy as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Natural Killer Cell Therapy Revenue in 2024
Figure 18. North America Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Natural Killer Cell Therapy Market Share by Country (2020-2031)
Figure 20. United States Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Natural Killer Cell Therapy Market Share by Country (2020-2031)
Figure 24. Germany Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Natural Killer Cell Therapy Market Share by Region (2020-2031)
Figure 32. China Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Natural Killer Cell Therapy Market Share by Country (2020-2031)
Figure 40. Mexico Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Natural Killer Cell Therapy Market Share by Country (2020-2031)
Figure 44. Turkey Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Nektar Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2020-2025)
Figure 48. Innate Pharma SA Revenue Growth Rate in Natural Killer Cell Therapy Business (2020-2025)
Figure 49. Affimed Revenue Growth Rate in Natural Killer Cell Therapy Business (2020-2025)
Figure 50. Chipscreen Biosciences Revenue Growth Rate in Natural Killer Cell Therapy Business (2020-2025)
Figure 51. Glycostem Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2020-2025)
Figure 52. Fate Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2020-2025)
Figure 53. Dragonfly Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2020-2025)
Figure 54. Kiadis Pharma Revenue Growth Rate in Natural Killer Cell Therapy Business (2020-2025)
Figure 55. Nkarta Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2020-2025)
Figure 56. NantKwest Revenue Growth Rate in Natural Killer Cell Therapy Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Table 1. Global Natural Killer Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of NK Cell Therapies
Table 3. Key Players of NK Cell Directed Antibodies
Table 4. Global Natural Killer Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Natural Killer Cell Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Natural Killer Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Natural Killer Cell Therapy Market Share by Region (2020-2025)
Table 8. Global Natural Killer Cell Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Natural Killer Cell Therapy Market Share by Region (2026-2031)
Table 10. Natural Killer Cell Therapy Market Trends
Table 11. Natural Killer Cell Therapy Market Drivers
Table 12. Natural Killer Cell Therapy Market Challenges
Table 13. Natural Killer Cell Therapy Market Restraints
Table 14. Global Natural Killer Cell Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Natural Killer Cell Therapy Market Share by Players (2020-2025)
Table 16. Global Top Natural Killer Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cell Therapy as of 2024)
Table 17. Ranking of Global Top Natural Killer Cell Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Natural Killer Cell Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Natural Killer Cell Therapy, Headquarters and Area Served
Table 20. Global Key Players of Natural Killer Cell Therapy, Product and Application
Table 21. Global Key Players of Natural Killer Cell Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Natural Killer Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Natural Killer Cell Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global Natural Killer Cell Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Natural Killer Cell Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global Natural Killer Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Natural Killer Cell Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global Natural Killer Cell Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Natural Killer Cell Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America Natural Killer Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Natural Killer Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Natural Killer Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Natural Killer Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Natural Killer Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Natural Killer Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Natural Killer Cell Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Natural Killer Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Natural Killer Cell Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Natural Killer Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Natural Killer Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Natural Killer Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Natural Killer Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Natural Killer Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Natural Killer Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Nektar Therapeutics Company Details
Table 47. Nektar Therapeutics Business Overview
Table 48. Nektar Therapeutics Natural Killer Cell Therapy Product
Table 49. Nektar Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025) & (US$ Million)
Table 50. Nektar Therapeutics Recent Development
Table 51. Innate Pharma SA Company Details
Table 52. Innate Pharma SA Business Overview
Table 53. Innate Pharma SA Natural Killer Cell Therapy Product
Table 54. Innate Pharma SA Revenue in Natural Killer Cell Therapy Business (2020-2025) & (US$ Million)
Table 55. Innate Pharma SA Recent Development
Table 56. Affimed Company Details
Table 57. Affimed Business Overview
Table 58. Affimed Natural Killer Cell Therapy Product
Table 59. Affimed Revenue in Natural Killer Cell Therapy Business (2020-2025) & (US$ Million)
Table 60. Affimed Recent Development
Table 61. Chipscreen Biosciences Company Details
Table 62. Chipscreen Biosciences Business Overview
Table 63. Chipscreen Biosciences Natural Killer Cell Therapy Product
Table 64. Chipscreen Biosciences Revenue in Natural Killer Cell Therapy Business (2020-2025) & (US$ Million)
Table 65. Chipscreen Biosciences Recent Development
Table 66. Glycostem Therapeutics Company Details
Table 67. Glycostem Therapeutics Business Overview
Table 68. Glycostem Therapeutics Natural Killer Cell Therapy Product
Table 69. Glycostem Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025) & (US$ Million)
Table 70. Glycostem Therapeutics Recent Development
Table 71. Fate Therapeutics Company Details
Table 72. Fate Therapeutics Business Overview
Table 73. Fate Therapeutics Natural Killer Cell Therapy Product
Table 74. Fate Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025) & (US$ Million)
Table 75. Fate Therapeutics Recent Development
Table 76. Dragonfly Therapeutics Company Details
Table 77. Dragonfly Therapeutics Business Overview
Table 78. Dragonfly Therapeutics Natural Killer Cell Therapy Product
Table 79. Dragonfly Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025) & (US$ Million)
Table 80. Dragonfly Therapeutics Recent Development
Table 81. Kiadis Pharma Company Details
Table 82. Kiadis Pharma Business Overview
Table 83. Kiadis Pharma Natural Killer Cell Therapy Product
Table 84. Kiadis Pharma Revenue in Natural Killer Cell Therapy Business (2020-2025) & (US$ Million)
Table 85. Kiadis Pharma Recent Development
Table 86. Nkarta Therapeutics Company Details
Table 87. Nkarta Therapeutics Business Overview
Table 88. Nkarta Therapeutics Natural Killer Cell Therapy Product
Table 89. Nkarta Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025) & (US$ Million)
Table 90. Nkarta Therapeutics Recent Development
Table 91. NantKwest Company Details
Table 92. NantKwest Business Overview
Table 93. NantKwest Natural Killer Cell Therapy Product
Table 94. NantKwest Revenue in Natural Killer Cell Therapy Business (2020-2025) & (US$ Million)
Table 95. NantKwest Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Natural Killer Cell Therapy Picture
Figure 2. Global Natural Killer Cell Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Natural Killer Cell Therapy Market Share by Type: 2024 VS 2031
Figure 4. NK Cell Therapies Features
Figure 5. NK Cell Directed Antibodies Features
Figure 6. Global Natural Killer Cell Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Natural Killer Cell Therapy Market Share by Application: 2024 VS 2031
Figure 8. Cancer Case Studies
Figure 9. Gastrointestinal Diseases Case Studies
Figure 10. Others Case Studies
Figure 11. Natural Killer Cell Therapy Report Years Considered
Figure 12. Global Natural Killer Cell Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Natural Killer Cell Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Natural Killer Cell Therapy Market Share by Region: 2024 VS 2031
Figure 15. Global Natural Killer Cell Therapy Market Share by Players in 2024
Figure 16. Global Top Natural Killer Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cell Therapy as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Natural Killer Cell Therapy Revenue in 2024
Figure 18. North America Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Natural Killer Cell Therapy Market Share by Country (2020-2031)
Figure 20. United States Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Natural Killer Cell Therapy Market Share by Country (2020-2031)
Figure 24. Germany Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Natural Killer Cell Therapy Market Share by Region (2020-2031)
Figure 32. China Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Natural Killer Cell Therapy Market Share by Country (2020-2031)
Figure 40. Mexico Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Natural Killer Cell Therapy Market Share by Country (2020-2031)
Figure 44. Turkey Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Natural Killer Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Nektar Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2020-2025)
Figure 48. Innate Pharma SA Revenue Growth Rate in Natural Killer Cell Therapy Business (2020-2025)
Figure 49. Affimed Revenue Growth Rate in Natural Killer Cell Therapy Business (2020-2025)
Figure 50. Chipscreen Biosciences Revenue Growth Rate in Natural Killer Cell Therapy Business (2020-2025)
Figure 51. Glycostem Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2020-2025)
Figure 52. Fate Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2020-2025)
Figure 53. Dragonfly Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2020-2025)
Figure 54. Kiadis Pharma Revenue Growth Rate in Natural Killer Cell Therapy Business (2020-2025)
Figure 55. Nkarta Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2020-2025)
Figure 56. NantKwest Revenue Growth Rate in Natural Killer Cell Therapy Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232